AI-generated summary
The authors randomized 52 adults with myogenic temporomandibular disorders to photobiomodulation plus the Rocabado approach or placebo photobiomodulation plus the same approach, over 6 weeks. They report that the photobiomodulation group showed greater improvements in pain threshold, pain intensity, mouth opening and jaw function scores, though both groups improved.
- Participants
- 52
- Who or what was studied
- Adults aged 18 to 40 years with myogenic temporomandibular disorders
- Limits stated in the abstract
- The abstract does not report the light parameters used, and the study compares against a placebo arm within a single trial rather than a broader evidence base.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Randomized controlled trial, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.